Mauro Moroni
Overview
Explore the profile of Mauro Moroni including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
56
Citations
1365
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zuccarini A, Cicognini D, Tancredi R, Ferrari A, Rizzo G, Lasagna A, et al.
Support Care Cancer
. 2022 Jun;
30(9):7645-7653.
PMID: 35678882
Background: Iron supplementation improves the erythropoiesis-stimulating agents' (ESAs) response in chemotherapy-related anemia. The primary aim of our study is to assess the efficacy of sucrosomial iron, a new oral iron...
2.
Artale S, Grillo N, Lepori S, Butti C, Bovio A, Barzaghi S, et al.
Nutrients
. 2022 May;
14(9).
PMID: 35565769
This study aimed to determine if dietary modifications using a nutritional regimen could prevent or reduce the incidence of cancer therapy-induced diarrhea in patients with metastatic colorectal cancer and to...
3.
Barni S, Rosati G, Lonardi S, Pella N, Banzi M, Zampino M, et al.
Ther Adv Med Oncol
. 2020 Feb;
12:1758835919899850.
PMID: 32010236
Background: The risk of venous thromboembolic events (VTE) during adjuvant chemotherapy for colorectal cancer (CRC) is unknown. We aim to evaluate if the Khorana score (KS) can predict this risk,...
4.
Moroni M, Stella M, Pedrazzoli P, Pirovano M, Boveri E, Veronese S
Acta Oncol
. 2016 Sep;
55(11):1373-1375.
PMID: 27579625
No abstract available.
5.
De Giorgi U, Yuan J, Moroni M, Veronese S, Sartore-Bianchi A, Broggini M, et al.
Int J Biol Markers
. 2015 May;
30(3):e275-81.
PMID: 25982682
Germ cell tumors (GCTs) generally express wild-type p53 protein. Rare p53 mutations may be associated with cisplatin resistance. There is growing interest in the role of cyclins as targets for...
6.
Ricotta R, Vanzulli A, Moroni M, Colnago B, Oriani M, Nichelatti M, et al.
Clin Colorectal Cancer
. 2012 Oct;
12(1):45-53.
PMID: 23041354
Unlabelled: We show that detection, by week-2 magnetic resonance imaging, of tumor shrinkage >10% in response to therapy with cetuximab or panitumumab for metastatic colorectal carcinoma represents an early indicator...
7.
Antinori A, Marcotullio S, Ammassari A, Andreoni M, Angarano G, Armignacco O, et al.
New Microbiol
. 2012 Jun;
35(2):113-59.
PMID: 22707127
No abstract available.
8.
9.
10.
Sartore-Bianchi A, Fieuws S, Veronese S, Moroni M, Personeni N, Frattini M, et al.
J Clin Pathol
. 2011 Dec;
65(3):218-23.
PMID: 22130903
Aims: Epidermal growth factor receptor (EGFR) gene copy number evaluated by fluorescence in situ hybridisation (FISH) can discriminate among KRAS wild-type patients those with better outcome to EGFR-targeted therapy in...